Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Ganaxolone reduces seizure frequency in patients with CDKL5 deficiency disorder
Ganaxolone was generally well tolerated and significantly reduced the frequency of seizures associated with CDKL5 deficiency disorder, according to a study published in The Lancet Neurology.
Familial hypercholesterolemia, long-term statin use not linked to risk for dementia
People with familial hypercholesterolemia and those on long-term, high-intensity statins had no greater risk for dementia than matched controls, per a study published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
CAR-T effective, safe for certain patients with central nervous system-involved lymphoma
SALT LAKE CITY — Chimeric antigen receptor T-cell therapy appeared effective for patients with primary or secondary central nervous system large B-cell lymphoma, according to study results.
Benefits of ticagrelor, aspirin for stroke outweigh risks over 30 days
The benefits of ticagrelor and aspirin outweighed the risk for major hemorrhage in patients with mild to moderate ischemic stroke or at high risk for transient ischemic attack during 30 days of treatment, according to a Neurology study.
Q&A: Electronic health records bring 'extraordinary opportunities' for care
Satisfaction and support for electronic health records were significantly higher among physicians working in physician-owned practices than those in non-physician-owned practices, according to findings published in JAMA Network Open.
Neurodevelopment in infants with CHD may be predicted in utero
DENVER — Selective impairments in regional fetal brain growth predicted adverse development among infants with congenital heart disease, according to study findings presented at the Pediatric Academic Societies Meeting.
App-based mental exercises improve cognitive impairment
Those with amnestic mild cognitive impairment who used the BrainHQ app for visual speed and attention exercises improved neuropsychological measures of speed, attention, memory and connectivity.
FDA grants breakthrough device designation for MS plasma test
The FDA has granted breakthrough device designation to Quanterix Corp. for its Simoa neurofilament light chain plasma test, a prognostic aid that assesses risk for disease activity in patients with relapsing-remitting MS.
HHS, White House announce new initiative to reduce emissions in health care
In celebration of Earth Day, HHS, in partnership with the White House, has announced a pledge initiative calling for reduced emissions across the health care sector.
Phase 2 trial shows promising results for oral Parkinson’s treatment
Neuroscience company Cerevance announced the completion of its phase 2 clinical trial of CVN424, a once-daily oral compound developed for the treatment of Parkinson’s disease.
-
Headline News
Advances in life expectancy have slowed, with major gains ‘implausible in this century’
October 07, 20243 min read -
Headline News
Four children's hospitals claim top spots in U.S. News & World Report ranking
October 08, 20242 min read -
Headline News
FDA reviewing application for bemotrizinol as first new sunscreen ingredient since 1999
October 07, 20241 min read
-
Headline News
Advances in life expectancy have slowed, with major gains ‘implausible in this century’
October 07, 20243 min read -
Headline News
Four children's hospitals claim top spots in U.S. News & World Report ranking
October 08, 20242 min read -
Headline News
FDA reviewing application for bemotrizinol as first new sunscreen ingredient since 1999
October 07, 20241 min read